We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-4.64%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$11.8B
AUM Growth
+$1.34B
Cap. Flow
+$2.18B
Cap. Flow %
18.39%
Top 10 Hldgs %
3.51%
Holding
4,052
New
613
Increased
1,643
Reduced
1,246
Closed
518

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$34.6M
2
WDAY icon
Workday
WDAY
+$33.5M
3
FRC
First Republic Bank
FRC
+$31.8M
4
ZTS icon
Zoetis
ZTS
+$31.3M
5
SYF icon
Synchrony
SYF
+$31M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$35.7M
2
HON icon
Honeywell
HON
+$31.7M
3
IP icon
International Paper
IP
+$30.5M
4
ADM icon
Archer Daniels Midland
ADM
+$23.8M
5
EMR icon
Emerson Electric
EMR
+$22.5M

Sector Composition

Rank Sector Weight
1 Technology 18.12%
2 Financials 17.75%
3 Healthcare 12.17%
4 Consumer Discretionary 11.8%
5 Industrials 11.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONCT
3451
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$28K ﹤0.01%
+995
New +$36.2K
BEKE icon
3452
KE Holdings
BEKE
$19.5B
$27K ﹤0.01%
2,204
-6,039
-73% -$108K
NU icon
3453
Nu Holdings
NU
$67B
$27K ﹤0.01%
+3,516
New +$28.2K
RDNT icon
3454
RadNet
RDNT
$6.08B
$27K ﹤0.01%
1,226
-7,781
-86% -$190K
WPRT
3455
Westport Fuel Systems
WPRT
$35.7M
$27K ﹤0.01%
1,662
-1,230
-43% -$22K
SPRB
3456
Spruce Biosciences
SPRB
$127M
$27K ﹤0.01%
176
-365
-67% -$67.9K
SDC
3457
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$27K ﹤0.01%
+10,574
New +$24.5K
KDNY
3458
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$27K ﹤0.01%
1,650
-55,801
-97% -$759K
PHAS
3459
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$27K ﹤0.01%
+20,143
New +$32.7K
SAGAR
3460
DELISTED
Sagaliam Acquisition Corp. Rights
SAGAR
$26K ﹤0.01%
+149,451
New +$30.2K
ACT icon
3461
Enact Holdings
ACT
$6.67B
$25K ﹤0.01%
1,121
-42,872
-97% -$925K
CTMX icon
3462
CytomX Therapeutics
CTMX
$750M
$25K ﹤0.01%
9,346
– –
HORIW
3463
DELISTED
Emerging Markets Horizon Corp. Warrants
HORIW
$25K ﹤0.01%
+157,431
New +$37.1K
ARCKW
3464
DELISTED
Arbor Rapha Capital Bioholdings Corp. I Warrants
ARCKW
$25K ﹤0.01%
+132,748
New +$48.7K
SPB icon
3465
Spectrum Brands
SPB
$2.02B
$24K ﹤0.01%
274
-46,765
-99% -$4.3M
SYRS
3466
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$24K ﹤0.01%
2,055
-477
-19% -$8.53K
RMO
3467
DELISTED
Romeo Power, Inc.
RMO
$24K ﹤0.01%
+16,248
New +$34.2K
DNN icon
3468
Denison Mines
DNN
$2.95B
$23K ﹤0.01%
14,200
-173,050
-92% -$244K
LXRX icon
3469
Lexicon Pharmaceuticals
LXRX
$1.07B
$23K ﹤0.01%
10,816
-55,992
-84% -$155K
SIEN
3470
DELISTED
Sientra, Inc.
SIEN
$23K ﹤0.01%
1,035
-379
-27% -$10.4K
TIPT icon
3471
Tiptree Inc
TIPT
$673M
$22K ﹤0.01%
1,683
-5,886
-78% -$75.7K
ABOS icon
3472
Acumen Pharmaceuticals
ABOS
$176M
$21K ﹤0.01%
5,387
-6,158
-53% -$33.5K
IMCR icon
3473
Immunocore
IMCR
$1.73B
$21K ﹤0.01%
+688
New +$17.4K
SNY icon
3474
Sanofi
SNY
$104B
$21K ﹤0.01%
411
– –
VIOT
3475
Viomi Technology
VIOT
$49.5M
$21K ﹤0.01%
+11,842
New +$23K
137 138
139
140 141

Similar funds

GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM
ECM
Eisler Capital Management London, United Kingdom $22.6B AUM 9.36% 1-Year Est. Return
JFL
Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
WIM
Waverton Investment Management London, United Kingdom $7.77B AUM 25.07% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Cubist Systematic Strategies's Q1 2022 Portfolio in Review

As of Q1 2022, Cubist Systematic Strategies held 4,052 positions worth $11.8B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

Cubist Systematic Strategies deployed $2.18B of net new capital in Q1 2022, opening 613 new positions and adding to 1,643 existing holdings. Its largest new stake was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Medtronic, an estimated $35.7M trimmed.

  • Cubist Systematic Strategies's largest Q1 2022 buy was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
  • Cubist Systematic Strategies added most to Abbott in Q1 2022, an estimated $34.6M increase.
  • Cubist Systematic Strategies's biggest Q1 2022 reduction was Medtronic, cutting an estimated $35.7M.
  • Cubist Systematic Strategies fully exited Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant in Q1 2022, selling an estimated $20.6M.
  • Cubist Systematic Strategies's ten largest holdings make up 3.5% of its $11.8B portfolio in Q1 2022.
  • Cubist Systematic Strategies opened 613 new positions and closed 518 in Q1 2022.
  • Cubist Systematic Strategies's portfolio value rose 13% quarter-over-quarter to $11.8B.

Based on Cubist Systematic Strategies's 13F filing for Q1 2022, filed 16 May 2022.